Alkermes News, Alkermes Quote, ALKS Quote

Alkermes (NQ:ALKS) Delayed: 55.08 +2.25 (4.26%)

Prev. Close

$52.83

Today 6M 1Y 5Y

Open

$52.87

52 Wk High

$80.71

52 Wk Low

$27.14

Day High

$55.28

Day Low

$52.39

P/E

423.69

EPS

$0.13

Volume

7,563,601

Friends, Peers and Foes (?): AVDL, CNTA, AMGN, AXSM, BHVN (more...)

ALERTS | RSS

Jun 24, 2026 07:11 AM Alkermes (ALKS) PT Raised to $61 at Needham
Jun 22, 2026 08:26 AM Alkermes (ALKS) PT Raised to $50 at TD Cowen
Jun 18, 2026 07:05 AM Alkermes (ALKS) PT Raised to $54 at Needham
Jun 18, 2026 06:43 AM H.C. Wainwright Reiterates Neutral Rating on Alkermes (ALKS)
Jun 17, 2026 04:15 PM Alkermes narcolepsy drug meets phase 2 trial endpoints
Jun 17, 2026 04:15 PM Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026
Jun 15, 2026 07:10 AM Form 8-K Alkermes plc. For: Jun 15
Jun 15, 2026 07:02 AM Alkermes receives orphan drug status for alixorexton in U.S. and Europe
Jun 15, 2026 07:00 AM Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe
Jun 12, 2026 08:04 PM Form 4 Alkermes plc. For: Jun 12 Filed by: Wright Christopher I

Entities mentioned with ALKS

View All Entities